awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38224967-9697DC81-7478-4CE7-8B6C-0FF495B7F2DF
Q38224967-9697DC81-7478-4CE7-8B6C-0FF495B7F2DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38224967-9697DC81-7478-4CE7-8B6C-0FF495B7F2DF
Acquired resistance to TKIs in solid tumours: learning from lung cancer.
P2860
Q38224967-9697DC81-7478-4CE7-8B6C-0FF495B7F2DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38224967-9697DC81-7478-4CE7-8B6C-0FF495B7F2DF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
00a27d21b11f9052998158c4d6011a82148dd02e
P2860
Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations.